Carcinogenesis Advance Access published online on March 7, 2006
Carcinogenesis, doi:10.1093/carcin/bgl004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Nelson Institute of Environmental Medicine, New York University, School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987
* To whom correspondence should be addressed. Although it has been well-established that insoluble nickel compounds are potent carcinogens and soluble nickel compounds are less potent, the mechanisms remain unclear. Nickel compounds are weakly mutagenic, but cause epigenetic effects in cells. Previous studies have shown that insoluble nickel compounds enter cells by phagocytosis and silence gene expression, but the entry of soluble nickel compounds and their effects on gene silencing have not been well studied. Here, we demonstrated using a dye that fluoresces when nickel ions bind, that soluble nickel compounds were found to be taken up by cells. Nickel ions initially localized in the cytoplasm, but later entered the nucleus, and eventually silenced a transgene. In addition, we described three major changes in histone modification of cells exposed to soluble nickel compounds: 1) loss of acetylation of H2A, H2B, H3, and H4; 2) increases of H3 K9 dimethylation; 3) substantial increases of the ubiquitination of H2A and H2B. These effects were observed at nickel exposure conditions that had minimum effects on cell cytotoxicity. Moreover, we demonstrated that nickel-induced transgene silencing was associated with similar changes of histone modifications in their nuclesomes. This study is the first to show nickel compounds increase histone ubiquitination in cells. These new findings will further our understanding of the epigenetic mechanisms of nickel-mediated carcinogenesis.
Received January 12, 2006
Revised February 22, 2006
Accepted February 28, 2006
CARCINOGENESIS
Alterations of histone modifications and transgene silencing by nickel chloride
Qingdong Ke 1,
Todd Davidson 1,
Haobin Chen 1,
Thomas Kluz 1,
and
Max Costa 1 *
Max Costa, E-mail: costam01{at}nyu.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Q. Li, Q. Ke, and M. Costa Alterations of histone modifications by cobalt compounds Carcinogenesis, July 1, 2009; 30(7): 1243 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Jensen, P. Novak, K. E. Eblin, A. J. Gandolfi, and B. W. Futscher Epigenetic remodeling during arsenical-induced malignant transformation Carcinogenesis, August 1, 2008; 29(8): 1500 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ji, L. Yang, L. Yu, J. Yuan, D. Hu, W. Zhang, J. Yang, Y. Pang, W. Li, J. Lu, et al. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells Carcinogenesis, June 1, 2008; 29(6): 1267 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ke, Q. Li, T. P. Ellen, H. Sun, and M. Costa Nickel compounds induce phosphorylation of histone H3 at serine 10 by activating JNK-MAPK pathway Carcinogenesis, June 1, 2008; 29(6): 1276 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Herceg Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors Mutagenesis, March 1, 2007; 22(2): 91 - 103. [Abstract] [Full Text] [PDF] |
||||

